Data / Form D filings / PBS Biotech, Inc.
PBS Biotech, Inc.: Form D filings
PBS Biotech, Inc., a biotechnology company in Camarillo, CA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on September 24, 2024, reports $8.5 million sold of a $17 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4721 Calle Carga, Camarillo, CA, 93012
- Phone
- (805) 482-7272
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1962718
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 24, 2024 | New notice | $16,999,997 | $8,499,999 | $8,499,998 | 3 | Sep 11, 2024 | sec.gov |
| Jan 20, 2023 | New notice | $34,706,776 | $34,706,776 | 3 | Dec 16, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Xiaoshen Liao | Director | |
| Brian Lee | Executive Officer, Director | |
| Daniel Friedman | Director | |
| Matt Croughan | Executive Officer | |
| Nelson Bermudez | Executive Officer | |
| Terrell Mathews | Executive Officer | |
| Dennis Fenton | Director | |
| Leland Foster | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 23, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PBS Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.